X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6728) 6728
Publication (924) 924
Book Chapter (33) 33
Book Review (23) 23
Dissertation (22) 22
Conference Proceeding (17) 17
Book / eBook (4) 4
Magazine Article (3) 3
Data Set (2) 2
Paper (2) 2
Web Resource (2) 2
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4346) 4346
index medicus (4099) 4099
female (3971) 3971
breast cancer (3822) 3822
oncology (3046) 3046
triple negative breast neoplasms - pathology (2186) 2186
triple-negative breast cancer (1984) 1984
middle aged (1683) 1683
cancer (1661) 1661
cell line, tumor (1518) 1518
prognosis (1483) 1483
adult (1391) 1391
triple negative breast neoplasms - genetics (1387) 1387
metastasis (1372) 1372
triple negative breast neoplasms - metabolism (1348) 1348
triple negative breast neoplasms - drug therapy (1302) 1302
chemotherapy (1283) 1283
expression (1269) 1269
aged (1206) 1206
triple negative breast cancer (1155) 1155
tumors (1116) 1116
animals (1081) 1081
breast neoplasms - pathology (970) 970
survival (925) 925
gene expression (830) 830
analysis (825) 825
mice (810) 810
apoptosis (805) 805
research (769) 769
breast neoplasms - metabolism (748) 748
immunohistochemistry (722) 722
cell biology (707) 707
care and treatment (669) 669
article (635) 635
gene expression regulation, neoplastic (634) 634
health aspects (634) 634
cancer therapies (619) 619
receptor, erbb-2 - metabolism (594) 594
therapy (592) 592
carcinoma (582) 582
medical prognosis (582) 582
genetic aspects (575) 575
cells (570) 570
medicine & public health (559) 559
triple negative (550) 550
receptors, estrogen - metabolism (543) 543
breast (542) 542
proteins (522) 522
subtypes (518) 518
neoplasm staging (511) 511
disease-free survival (504) 504
aged, 80 and over (487) 487
breast neoplasms - genetics (477) 477
pathology (474) 474
triple negative breast neoplasms - mortality (467) 467
receptors, progesterone - metabolism (457) 457
treatment outcome (456) 456
cell proliferation - drug effects (453) 453
breast neoplasms - drug therapy (449) 449
estrogen (446) 446
growth (444) 444
research article (435) 435
antineoplastic agents - pharmacology (431) 431
development and progression (430) 430
retrospective studies (426) 426
biochemistry & molecular biology (405) 405
cell proliferation (404) 404
epidermal growth factor (401) 401
mutation (401) 401
phenotype (397) 397
xenograft model antitumor assays (397) 397
neoadjuvant chemotherapy (393) 393
signal transduction (389) 389
antineoplastic combined chemotherapy protocols - therapeutic use (378) 378
biomarkers, tumor - metabolism (374) 374
medicine (368) 368
metastases (364) 364
antineoplastic agents - therapeutic use (360) 360
triple negative breast neoplasms - therapy (359) 359
apoptosis - drug effects (352) 352
identification (345) 345
kaplan-meier estimate (342) 342
kinases (342) 342
biomarkers (336) 336
skin and connective tissue diseases (336) 336
activation (335) 335
women (335) 335
patients (334) 334
risk factors (333) 333
surgery (330) 330
proliferation (329) 329
breast neoplasms - mortality (328) 328
research paper (328) 328
studies (327) 327
medicine, research & experimental (320) 320
inhibition (318) 318
estrogen-receptor (312) 312
epithelial-mesenchymal transition (311) 311
mice, nude (309) 309
genes (308) 308
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6562) 6562
Chinese (54) 54
French (52) 52
Japanese (31) 31
Spanish (25) 25
Russian (22) 22
German (17) 17
Czech (8) 8
Korean (7) 7
Polish (7) 7
Portuguese (3) 3
Bulgarian (1) 1
Croatian (1) 1
Hungarian (1) 1
Latvian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 03/2019, Volume 30, Issue 3, pp. 397 - 404
Abstract Background Treatment options for previously treated metastatic triple-negative breast cancer (mTNBC) are limited. In cohort A of the phase II... 
pembrolizumab | triple-negative breast neoplasms | anti-PD-1 | immunotherapy | ONCOLOGY | PD-L1 EXPRESSION | ANTIBODY
Journal Article
Human Pathology, ISSN 0046-8177, 2012, Volume 43, Issue 3, pp. 364 - 373
Summary Women classified as having triple-negative tumors have a poor prognosis. The importance of CD44+ /CD24−/low (stem/progenitor cell-phenotype) in breast... 
Pathology | Recurrence | Breast cancer | Triple negative | Stem cell phenotype | Chemotherapy | Cancer therapies | Stem cells | Tumors
Journal Article
Seminars in Cancer Biology, ISSN 1044-579X, 10/2019
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 10/2018, Volume 57, Issue 40, pp. 13349 - 13349
A rhodium(III)‐based inhibitor of lysine‐specific demethylase 5A has been developed. In their Commmunication on page 13091 ff., V. K. W. Wong, D. L. Ma, C.‐H.... 
triple-negative breast cancer | drug discovery | epigenetics | medicinal chemistry
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2019, Volume 19, Issue 1, pp. 1 - 9
Abstract Background Triple negative breast cancer (TNBC) represents 15–20% of breast cancers. Due to its heterogeneity and high rates of relapse, there is a... 
Platinum chemotherapy | Triple negative breast cancer
Journal Article
Biochemical and biophysical research communications, ISSN 0006-291X, 9/2018, Volume 503, Issue 2, pp. 1087 - 1091
Triple negative breast cancer (TNBC) is among the most aggressive breast cancer subtypes with poor prognosis. The purpose of this study is to better understand... 
microRNA | triple negative breast cancer | invasion | HDAC9 | angiogenesis
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 08/2012, Volume 23, pp. 7 - 12
Breast cancer in advanced age has been associated with a slightly increased probability of favourable tumour biology (e.g. hormone receptor-positive and human... 
SURVIVAL | treatment | INCIDENCE RATES | triple-negative breast cancer | SUBTYPES | elderly | PHENOTYPE | chemotherapy | prognosis | ESTROGEN-RECEPTOR | WOMEN | ONCOLOGY | geriatric | PROGESTERONE-RECEPTOR | EPIDEMIOLOGY | BASAL | AGE
Journal Article
Cancer, ISSN 0008-543X, 11/2010, Volume 116, Issue 21, pp. 4926 - 4932
BACKGROUND: The study of breast cancer in women with African ancestry offers the promise of identifying markers for risk assessment and treatment of... 
triple negative | African ancestry | breast cancer | white American | race | African American | Breast cancer | White American | Triple negative | Race
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2013, Volume 110, Issue 41, pp. E3937 - E3944
Journal Article
Journal of Clinical and Diagnostic Research, ISSN 2249-782X, 02/2018, Volume 12, Issue 2, pp. EC01 - EC04
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2019, Volume 30, Issue 3, pp. 405 - 411
Abstract Background Standard first-line treatment of metastatic triple-negative breast cancer (mTNBC) is chemotherapy. However, outcomes are poor, and new... 
pembrolizumab | triple-negative breast neoplasms | ONCOLOGY | anti-PD-1 | PD-L1 EXPRESSION | immunotherapy
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.